Stock ALPMY ASTELLAS PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Relative Strength Chart Astellas Pharma Inc. OTC Markets

Equities

ALPMY

US04623U1025

Delayed OTC Markets
Other stock markets
 16:04:59 21/06/2024 BST 		5-day change 1st Jan Change
9.46 USD +0.75% Intraday chart for Astellas Pharma Inc. -0.53% -20.50%
06-03 US FDA Acknowledges Astellas Pharma's Resubmission of Biologics License Application for Zolbetuximab MT
05-31 U.S. Food and Drug Administration Acknowledges Astellas Pharma Inc.? Resubmission of Biologics License Application for Zolbetuximab and Sets New Action Date CI

End-of-day quotes

Compared values

Sector Change 5d. change 1st Jan change 1-year change 5-years change Capi. ST MT LT
ASTELLAS PHARMA INC.
Other Pharmaceuticals
+0.75%-0.53%-20.50%-39.24%-29.98% 16.91B - - -
  1. Stock Market
  2. Equities
  3. 4503 Stock
  4. ALPMY Stock
  5. Charts Astellas Pharma Inc.
  6. Relative Strength Chart